Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA’s adverse event reporting system: a case control pharmacovigilance study
2024 · BMC Pharmacology and Toxicology · 29 citations
https://doi.org/10.1186/s40360-024-00770-6